USPTO serial 88308560
LTS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 25, 2020
- Examiner
- NELMAN, JESSE M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with LTS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*
Plus Government fees of $2,125
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
LTS Lohmann Therapie-Systeme AG
Andernach, DE
LTS Lohmann Therapie-Systeme AG
Andernach, DE
LTS Lohmann Therapie-Systeme AG
Andernach, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kirk M. Miles, Registration No. 37,891
Kirk M. Miles, Registration No. 37,891 THE WEBB LAW FIRMONE GATEWAY CENTER420 FORT DUQUESNE BOULEVARD, SUITE 1200PITTSBURGH, PA 15222Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; adhesives used in industry | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations, namely, injectable pharmaceutical and veterinary preparations for the prevention and treatment of disease, namely, infectious diseases, viral diseases, neurological diseases, central nervous system diseases, brain diseases, oral and dental diseases, inflammatory diseases, immune system diseases, dermatological diseases, sexually transmitted diseases, musculoskeletal diseases, psychiatric diseases, diseases of the spinal cord and motor disorders, cardiovascular diseases, diseases of the respiratory system, diseases treated by oncologists, gastroenterologists, opthalmologists, otologists, audolaryngologists, gynecologists, gerontologists, proctologists, and urologists by intracutaneous, intradermal, subcutaneous, intramuscular, intravenous and intra-articular injection, the aforesaid injection preparations being for needle-free injection and for injection by means of needle and cannula systems; injectable pharmaceutical and veterinary preparation therapeutic or prophylactic ingredients or diagnostic preparations, namely, pharmaceutical and therapeutic preparations for use with pets, laboratory animals, wild animals, zoo animals and livestock for the treatment and prevention of disease, namely, infectious diseases, viral diseases, neurological diseases, central nervous system diseases, brain diseases, oral and dental diseases, inflammatory diseases, immune system diseases, dermatological diseases, sexually transmitted diseases, musculoskeletal diseases, psychiatric diseases, diseases of the spinal cord and motor disorders, cardiovascular diseases, diseases of the respiratory system, diseases treated by oncologists, gastroenterologists, opthalmologists, otologists, audolaryngologists, gynecologists, gerontologists, proctologists, and urologists; pharmaceutical preparations for use in the gastrointestinal tract, subcutaneous use and for oral use for the treatment and prevention of disease, namely, infectious diseases, viral diseases, neurological diseases, central nervous system diseases, brain diseases, oral and dental diseases, inflammatory diseases, immune system diseases, dermatological diseases, sexually transmitted diseases, musculoskeletal diseases, psychiatric diseases, diseases of the spinal cord and motor disorders, cardiovascular diseases, diseases of the respiratory system, diseases treated by oncologists, gastroenterologists, opthalmologists, otologists, audolaryngologists, gynecologists, gerontologists, proctologists, and urologists; medicines for administration in the form of plasters and wafers containing active ingredients, namely, medicines for the treatment of gastrointestinal diseases; medical plasters containing active ingredients for transdermal administration of active ingredients; medical plasters containing active ingredients for topical processing of active ingredients and for manufacturing active ingredient-free laminates; sanitary preparations for medical purposes; food for babies; dietary supplements for humans and animals; medical and surgical plasters in the nature of materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides | ACTIVE | — |
| 010 | Surgical, medical and veterinary apparatus and instruments, namely, instruments and apparatus for injecting substances, in particular, infusion and injection device for administering drugs, needle-free, via needles, by cannulae, and through an injection systems comprised primarily of a needle-free injection device; dropper bottle for administering medication, sold empty; medicine delivery devices and instruments, namely, microneedles and microneedle assemblies and structures for use in dermal, transdermal, mucosal and transmucosal administration of pharmaceuticals and biotechnological molecules; medicine delivery devices and instruments, namely, microneedles and microneedle assemblies for use in dermal, transdermal, mucosal and transmucosal sampling of bodily fluids; medical devices and instruments for administering pharmaceuticals and biotechnological molecules using needle-like microstructures; plaster needles for medical purposes for use on the skin; injection device for pharmaceuticals, namely, medical injection device for administering drugs and parts for the aforesaid goods, in particular, microneedles and microneedle assemblies for use in administering pharmaceuticals and biotechnological molecules, excluding dental apparatus and instruments; artificial limbs and eyes, excluding dental implants and prosthesis; suture materials; all of the aforesaid goods excluding dental products | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, chemical analysis and industrial research services in the field of chemical analysis; industrial analysis, namely, chemical analysis and industrial research services in the field of chemical analysis; design and development of computer hardware and software | ACTIVE | — |
| 044 | Medical services; veterinary services; hygienic and beauty care for human beings and animals; agriculture, horticulture and forestry services, namely, horticulture services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LTS Lohmann Therapie-Systeme AG
- Other trademarks owned by LTS Lohmann Therapie-Systeme AG
- Other trademarks owned by LTS Lohmann Therapie-Systeme AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named LTS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 25, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Aug 25, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 9, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 9, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 20, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 4, 2020 | ALIE | ASSIGNED TO LIE | — |
| Apr 27, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 27, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 27, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 27, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 27, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 21, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 21, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 21, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 7, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 30, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 30, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 30, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 3, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 1, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 21, 2019 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Mar 12, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 23, 2019 | NWAP | NEW APPLICATION ENTERED | — |